Resultados de la búsqueda 1801-1810 of 4637 for Blood factor II

  1. Oncología (médica) - Ensayos clínicos

    Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors. Rochester, Minn. The purpose of this study is to evaluate ...

  2. Oncología (médica) - Ensayos clínicos

    Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors. Rochester, Minn. The purpose of this study is to evaluate ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This project will investigate whether the analysis of nucleic acids circulating in the blood from tumors can allow real-time monitoring of treatment response to ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...

  5. Medicina cardiovascular - Ensayos clínicos

    ... factors for outcomes ... Molecular Analysis of Blood for the Detection of Cardiovascular Pathogens ... Ir a página 22 · Ir a página 33 · Ir a página 44 · Ir a ...

  6. Atresia pulmonar - Médicos y departamentos - Mayo Clinic

    Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri, Dec 05, 2025. See more discussions. Relacionado. Atresia pulmonar. Procedimientos ...

  7. Estenosis de la aorta - Médicos y departamentos - Mayo Clinic

    Connect with others like you for support and answers to your questions in the Heart & Blood Health support group on Mayo Clinic Connect, a patient community.

  8. Displasia fibromuscular - Médicos y departamentos - Mayo Clinic

    Mostrando 1-2 de doctores disponibles ... flebitis, Embolia pulmonar, Factor V de Leiden ... Connect with others like you for support and answers to your questions ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...